FRATES JAMES M

CIK 00012355984 companiesCAMBRIDGE, MA

SEC Profile

Transactions

Companies

Filings

CIK

0001235598

Recent Transactions

50 trades

Sale
Amylyx Pharmaceuticals, Inc.$AMLX
Common Stock
2026-01-06$11.11/sh−3,326→ 177,104 total
Sale
Amylyx Pharmaceuticals, Inc.$AMLX
Common Stock
2025-09-30$14.65/sh−10,558→ 280,430 total
Disposition from Tender
Sage Therapeutics, Inc.
Common Stock
2025-07-31−2,845→ 0 total
Disposition to Issuer
Sage Therapeutics, Inc.
Stock Option (Right to Buy)
2025-07-31−19,154→ 0 total
Disposition to Issuer
Sage Therapeutics, Inc.
Stock Option (Right to Buy)
2025-07-31−21,500→ 0 total
Award
Sage Therapeutics, Inc.
Stock Option (Right to Buy)
2025-06-11+21,500→ 21,500 total
Sale
Amylyx Pharmaceuticals, Inc.$AMLX
Common Stock
2025-03-31$3.47/sh−10,896→ 290,988 total
Award
Amylyx Pharmaceuticals, Inc.$AMLX
Stock Option (right to buy)
2025-03-06+102,630→ 102,630 total
Award
Amylyx Pharmaceuticals, Inc.$AMLX
Common Stock
2025-03-06+68,420→ 301,884 total
Award
Sage Therapeutics, Inc.
Stock Options (Right to buy)
2025-01-03+19,154→ 19,154 total
Purchase
Amylyx Pharmaceuticals, Inc.$AMLX
Common Stock
2024-09-12$2.53/sh+40,000→ 233,464 total
Award
Sage Therapeutics, Inc.
Stock Option (Right to Buy)
2024-06-10+12,500→ 12,500 total
Award
Amylyx Pharmaceuticals, Inc.$AMLX
Stock Option (right to buy)
2024-04-16+120,000→ 120,000 total
Award
Amylyx Pharmaceuticals, Inc.$AMLX
Common Stock
2024-04-16+91,180→ 225,964 total
Sale
Amylyx Pharmaceuticals, Inc.$AMLX
Common Stock
2024-03-05$18.73/sh−1,792→ 134,784 total
Award
Amylyx Pharmaceuticals, Inc.$AMLX
Stock Option (right to buy)
2024-02-26+60,000→ 60,000 total
Award
Amylyx Pharmaceuticals, Inc.$AMLX
Common Stock
2024-02-26+40,000→ 152,035 total
Sale
Amylyx Pharmaceuticals, Inc.$AMLX
Common Stock
2024-01-09$16.33/sh−2,716→ 112,035 total
Award
Sage Therapeutics, Inc.
Stock Options (Right to buy)
2024-01-03+4,925→ 4,925 total
Gift
Amylyx Pharmaceuticals, Inc.$AMLX
Common Stock
2023-10-31+11,072→ 11,072 total
Exercise/Conversion
Amylyx Pharmaceuticals, Inc.$AMLX
Common Stock
2023-08-23$6.88/sh+18,165→ 73,841 total
Exercise/Conversion
Amylyx Pharmaceuticals, Inc.$AMLX
Stock Option (right to buy)
2023-08-23−18,165→ 363,835 total
Exercise/Conversion
Amylyx Pharmaceuticals, Inc.$AMLX
Common Stock
2023-08-23$6.88/sh+18,165→ 106,341 total
Exercise/Conversion
Amylyx Pharmaceuticals, Inc.$AMLX
Stock Option (right to buy)
2023-08-23−18,165→ 363,835 total
Award
Sage Therapeutics, Inc.
Stock Option (Right to Buy)
2023-06-15+10,000→ 10,000 total
Sale
Amylyx Pharmaceuticals, Inc.$AMLX
Common Stock
2023-05-16$26.93/sh−32,000→ 56,176 total
Sale
Amylyx Pharmaceuticals, Inc.$AMLX
Common Stock
2023-05-16$27.60/sh−500→ 55,676 total
Exercise/Conversion
Amylyx Pharmaceuticals, Inc.$AMLX
Common Stock
2023-05-16$6.88/sh+32,500→ 88,176 total
Exercise/Conversion
Amylyx Pharmaceuticals, Inc.$AMLX
Stock Option (right to buy)
2023-05-16−32,500→ 382,000 total
Exercise/Conversion
Amylyx Pharmaceuticals, Inc.$AMLX
Common Stock
2023-03-16$6.88/sh+32,500→ 66,509 total
Exercise/Conversion
Amylyx Pharmaceuticals, Inc.$AMLX
Stock Option (right to buy)
2023-03-16−32,500→ 414,500 total
Sale
Amylyx Pharmaceuticals, Inc.$AMLX
Common Stock
2023-03-16$32.46/sh−1,704→ 34,009 total
Award
Amylyx Pharmaceuticals, Inc.$AMLX
Stock Option (right to buy)
2023-03-16+97,500→ 97,500 total
Sale
Amylyx Pharmaceuticals, Inc.$AMLX
Common Stock
2023-03-16$31.86/sh−30,796→ 35,713 total
Award
Amylyx Pharmaceuticals, Inc.$AMLX
Common Stock
2023-03-16+21,667→ 55,676 total
Award
Amylyx Pharmaceuticals, Inc.$AMLX
Common Stock
2023-03-16+21,667→ 23,176 total
Sale
Amylyx Pharmaceuticals, Inc.$AMLX
Common Stock
2023-03-16$31.86/sh−30,796→ 3,213 total
Sale
Amylyx Pharmaceuticals, Inc.$AMLX
Common Stock
2023-03-16$32.46/sh−1,704→ 1,509 total
Award
Amylyx Pharmaceuticals, Inc.$AMLX
Stock Option (right to buy)
2023-03-16+97,500→ 97,500 total
Sale
Amylyx Pharmaceuticals, Inc.$AMLX
Common Stock
2023-01-06$36.79/sh+822→ 34,009 total
Sale
Amylyx Pharmaceuticals, Inc.$AMLX
Common Stock
2023-01-06$36.08/sh+1,836→ 34,831 total
Exercise/Conversion
Amylyx Pharmaceuticals, Inc.$AMLX
Common Stock
2022-12-30$6.88/sh+5,000→ 36,667 total
Exercise/Conversion
Amylyx Pharmaceuticals, Inc.$AMLX
Stock Option (Right to Buy)
2022-12-30−5,000→ 447,000 total
Award
Sage Therapeutics, Inc.
Stock Option (Right to Buy)
2022-06-16+9,947→ 9,947 total
Award
Amylyx Pharmaceuticals, Inc.$AMLX
Stock Option (right to buy)
2022-02-11+25,000→ 25,000 total
Conversion
Amylyx Pharmaceuticals, Inc.$AMLX
Series C-1 Preferred Stock
2022-01-06−19,482→ 0 total
Award
Amylyx Pharmaceuticals, Inc.$AMLX
Common Stock
2022-01-06+31,667→ 31,667 total
Award
Amylyx Pharmaceuticals, Inc.$AMLX
Stock Option (right to buy)
2022-01-06+142,500→ 142,500 total
Conversion
Amylyx Pharmaceuticals, Inc.$AMLX
Common Stock
2022-01-06+19,482→ 19,482 total
Purchase
Sage Therapeutics, Inc.
Common Stock
2021-06-16$55.10/sh+1,810→ 1,810 total

Companies

Recent Filings

Address

C/O AMYLYX PHARMACEUTICALS, INC. 55 CAMBRIDGE PARKWAY, SUITE 6W

CAMBRIDGE, MA, 02142

View on SEC.gov